Abstract
One hundred forty sequential patients treated for endometrial adenocarcinoma between 1958 and 1966 at Stanford University Hospital are reported. The 5-year actuarial survival for the group was 75%. Tumor recurrence and prognosis correlated with histologic differentiation and depth of myometrial invasion. Stage I patients treated with surgery alone had a 5-year actuarial survival of 95% and a tumor recurrence rate of 2%. Routine preoperative irradiation does not appear to be necessary or logical in the treatment of Stage I endometrial carcinoma. Rather, postoperative radiation should be used for those Stage I patients whose tumors invade beyond 50% of the thickness of the myometrium as determined by pathologic examination of the uterus. Preoperative radiation therapy should be used for Stage II and III patients and possibly for Stage I patients with anaplastic carcinoma.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
